Cyclin dependent kinases in cancer
Author:
Publisher
Informa UK Limited
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.4161/cbt.19589
Reference63 articles.
1. Cyclin-dependent kinase inhibitors as potential targeted anticancer agents
2. Cyclin D-dependent kinases, INK4 inhibitors and cancer
3. Complexities in the development of cyclin-dependent kinase inhibitor drugs
4. CDK Inhibitors: Cell Cycle Regulators and Beyond
5. Cell cycle kinases as therapeutic targets for cancer
Cited by 135 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Molecules inducing specific cyclin-dependent kinase degradation and their possible use in cancer therapy;Future Medicinal Chemistry;2024-01-30
2. Nuclear localization signal-tagged systems: relevant nuclear import principles in the context of current therapeutic design;Chemical Society Reviews;2024
3. EIF2α/ATF4 pathway enhances proliferation of mesangial cell via cyclin D1 during endoplasmic reticulum stress in IgA nephropathy;Clinical Immunology;2023-12
4. Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients;Molecular Oncology;2023-09-28
5. Zebrafish as a robust preclinical platform for screening plant-derived drugs with anticonvulsant properties—a review;Frontiers in Molecular Neuroscience;2023-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3